Use of antibiotics in obstetric practice.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001692:Biological Transport; D001774:Blood Chemical Analysis; D002463:Cell Membrane Permeability; D002509:Cephaloridine / Q000009:adverse effects; D002701:Chloramphenicol / Q000009:adverse effects; D003091:Colistin / Q000009:adverse effects; D005321:Extraembryonic Membranes; D005260:Female; D005315:Fetal Diseases / Q000517:prevention & control; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D007612:Kanamycin / Q000009:adverse effects; D008431:Maternal-Fetal Exchange; D010406:Penicillins / Q000009:adverse effects; D010920:Placenta / Q000502:physiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011485:Protein Binding; D012421:Rupture / Q000188:drug therapy; D013307:Streptomycin / Q000009:adverse effects; D013752:Tetracycline / Q000009:adverse effects; D014470:Umbilical Cord
D000900:Anti-Bacterial Agents; D010406:Penicillins; D007612:Kanamycin; D002701:Chloramphenicol; D013752:Tetracycline; D002509:Cephaloridine; D007538:Isoniazid; D013307:Streptomycin; D003091:Colistin